相似文献
1
Vitamin D as a Potential Player in Immunologic Control over Multiple Myeloma Cells: Implications for Adjuvant Therapies.
Nutrients. 2022 Apr 26;14(9):1802. doi: 10.3390/nu14091802.
2
Vitamin D and K Supplementation Is Associated with Changes in the Methylation Profile of U266-Multiple Myeloma Cells, Influencing the Proliferative Potential and Resistance to Bortezomib.
Nutrients. 2023 Dec 31;16(1):142. doi: 10.3390/nu16010142.
3
Immunomodulation by vitamin D: implications for TB.
Expert Rev Clin Pharmacol. 2011 Sep;4(5):583-91. doi: 10.1586/ecp.11.41.
4
Applications of vitamin D in sepsis prevention.
Discov Med. 2018 Jun;25(140):291-297.
5
Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy.
Support Care Cancer. 2016 Jul;24(7):3105-10. doi: 10.1007/s00520-016-3126-1. Epub 2016 Feb 23.
6
Vitamin D changes expression of DNA repair genes in the patients with multiple sclerosis.
Gene. 2021 May 20;781:145488. doi: 10.1016/j.gene.2021.145488. Epub 2021 Feb 13.
7
Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes.
Int Immunopharmacol. 2021 Jun;95:107518. doi: 10.1016/j.intimp.2021.107518. Epub 2021 Mar 20.
8
The Association between Vitamin D and Gut Microbiota: A Systematic Review of Human Studies.
Nutrients. 2021 Sep 26;13(10):3378. doi: 10.3390/nu13103378.
9
A letter to the editor: High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study.
Support Care Cancer. 2023 Feb 27;31(3):188. doi: 10.1007/s00520-023-07648-z.
10
New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma.
Clin Cancer Res. 2016 Dec 15;22(24):5959-5965. doi: 10.1158/1078-0432.CCR-16-0184. Epub 2016 Oct 19.
引用本文的文献
1
Therapeutic Approaches for COVID-19: A Review of Antiviral Treatments, Immunotherapies, and Emerging Interventions.
Adv Ther. 2025 May 8. doi: 10.1007/s12325-025-03218-3.
2
Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma.
Biomedicines. 2024 Feb 24;12(3):514. doi: 10.3390/biomedicines12030514.
3
Vitamin D and K Supplementation Is Associated with Changes in the Methylation Profile of U266-Multiple Myeloma Cells, Influencing the Proliferative Potential and Resistance to Bortezomib.
Nutrients. 2023 Dec 31;16(1):142. doi: 10.3390/nu16010142.
4
The Global Prevalence of Vitamin D Deficiency and Insufficiency in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis.
Nutrients. 2023 Jul 20;15(14):3227. doi: 10.3390/nu15143227.
5
Vitamins and Human Health: Systematic Reviews and Original Research.
Nutrients. 2023 Jun 26;15(13):2888. doi: 10.3390/nu15132888.
6
Vitamin D and Multiple Myeloma: A Scoping Review.
Curr Oncol. 2023 Mar 11;30(3):3263-3276. doi: 10.3390/curroncol30030248.
本文引用的文献
1
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development.
Int J Mol Sci. 2022 Feb 23;23(5):2431. doi: 10.3390/ijms23052431.
2
The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma.
J Clin Med. 2021 Oct 4;10(19):4584. doi: 10.3390/jcm10194584.
3
High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study.
Support Care Cancer. 2022 Jan;30(1):271-278. doi: 10.1007/s00520-021-06414-3. Epub 2021 Jul 17.
4
Bortezomib induces methylation changes in neuroblastoma cells that appear to play a significant role in resistance development to this compound.
Sci Rep. 2021 May 10;11(1):9846. doi: 10.1038/s41598-021-89128-0.
5
Serum Levels of Vitamin D in Patients with Multiple Myeloma.
Folia Med (Plovdiv). 2020 Dec 31;62(4):730-735. doi: 10.3897/folmed.62.e50321.
6
Vitamin D Update.
Curr Dermatol Rep. 2020;9(4):323-330. doi: 10.1007/s13671-020-00315-0. Epub 2020 Oct 14.
7
Vitamin D levels in patients with non-Hodgkin lymphoma/diffuse large B-cell lymphoma, chronic lymphocytic leukemia and multiple myeloma.
J Int Med Res. 2020 Jul;48(7):300060520943421. doi: 10.1177/0300060520943421.
8
Immunologic Effects of Vitamin D on Human Health and Disease.
Nutrients. 2020 Jul 15;12(7):2097. doi: 10.3390/nu12072097.
9
Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels.
Hematol Oncol. 2020 Oct;38(4):523-530. doi: 10.1002/hon.2774. Epub 2020 Jul 29.
10
Vitamin K2 Needs an RDI Separate from Vitamin K1.
Nutrients. 2020 Jun 21;12(6):1852. doi: 10.3390/nu12061852.
Zotero 插件